Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02PPN
|
||||
Former ID |
DAP000024
|
||||
Drug Name |
Methylphenidate
|
||||
Synonyms |
Calocain; Centedein; Centedrin; Centredin; Concerta; Daytrana; Meridil; Metadate; MethyPatch; Methylfenidan; Methylin; Methylofenidan; Methylphen; Methylphenidan; Methylphenidatum; Metilfenidato; Phenidylate; Plimasine; Riphenidate; Ritalin; Ritaline; Tsentedrin; Metadate CD; Metadate ER; Methyl phenidate; Methyl phenidyl acetate; Methyl phenidylacetate; Methylin ER; Metilfenidato [Italian]; Ritalin LA; Ritalin SR; Ritcher works; C 4311; Attenta (TN); Biphentin (TN); Concerta (TN); D-methylphenidate HCl; Daytrana (TN); Equasym (TN); Metadate ER (TN); Methylin (TN); Methylphenidate [INN:BAN]; Methylphenidatum [INN-Latin]; Metilfenidato [INN-Spanish]; Motiron (TN); PMS-Methylphenidate; Ritalin (TN); Ritalin LA (TN); Ritalin-SR; Rubifen (TN); Methylphenidate (USAN/INN); Alpha-Phenyl-2-piperidineacetic acid methyl ester; Methyl phenyl(piperidin-2-yl)acetate; Methyl alpha-phenyl-alpha-2-piperidinylacetate; Alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester; Methyl 2-phenyl-2-piperidin-2-ylacetate; Methyl alpha-phenyl-alpha-(2-piperidyl)acetate; Methyl (2-phenyl-2-(2-piperidyl)acetate); METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R); 2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester; 2-Piperidineacetic acid, alpha-phenyl-, methyl ester
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Central Nervous System Stimulants
|
||||
Company |
Novartis
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H19NO2
|
||||
InChI |
InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3
|
||||
InChIKey |
DUGOZIWVEXMGBE-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 113-45-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9405, 5336253, 7979945, 8152600, 10504398, 14798219, 26746622, 29223265, 46505929, 47206727, 48416258, 49854760, 53789341, 57322165, 78286794, 85209963, 103209574, 103858000, 103958410, 104305599, 124954808, 127787857, 134337354, 134974024, 135709935, 136897384, 137007933, 142361369, 160963768, 163411030, 178103810, 179148478, 216106193, 223897828, 226423048, 249807024, 249948308, 252404612
|
||||
ChEBI ID |
ChEBI:6887
|
||||
SuperDrug ATC ID |
N06BA04
|
||||
SuperDrug CAS ID |
cas=000113451
|
||||
Target and Pathway | |||||
Target(s) | Sodium-dependent dopamine transporter | Target Info | Blocker | [536100] | |
Pathway Interaction Database | Alpha-synuclein signaling | ||||
References | |||||
Ref 536120 | Autism spectrum disorders: emerging pharmacotherapy. Expert Opin Emerg Drugs. 2005 Aug;10(3):521-36. | ||||
Ref 536713 | Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. | ||||
Ref 542252 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7236). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.